
Empowering independent CytoSorb® Therapy
*Not available in the US
CE-marked under MDR since 06/2024
Take care of your patients wherever and whenever they need the proven benefits of CytoSorbents’ hemoadsorption therapies.
PuriFi is specifically designed for application of CytoSorbents’ hemoadsorption solutions, allowing rapid training and quick and easy setup when needed. Designed with maximum mobility in mind, it can be used in the Emergency Room, in the Intensive Care Unit, or in Intermediate Care settings.
Overcome challenges by using CytoSorb in standalone configurations
Proven safety
Over 250,000 treatments administrated over the last ten years
Most peer-reviewed adsorber
Over 1,100 publications, abstracts, poster, manuscripts, and other resources.
Improved patient outcomes
With demonstrated efficacy across cardiovascular, kidney, liver, and critical care.
PuriFi at a glance
Additional Information
- Mitzner et al. J Clin Med. 2023;12(23):7199
- Schmoeckel et al., J Throm & Thrombolysis 2024; epub
- Doukas et al., J Clin Med 2023; 12:546
- Haidari et al., ICV&TS 2023; 36(1):ivad010
- Nemeth et al., ESC Heart Failure 2024; 11(2):772-782
- Grafe et al., Ren Fail 2023; 45(2):2259231
- Haselwanter et al., Sci Rep 2024; 14(1):11309
- Jansen et al., Critical Care 2023; 27(1):117
- Akil et al., J Clin Med 2022; 11(20):5990
CytoSorbents
Voices around the world
